Clinical Trial Update: Liposomal Bupivacaine After Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial of liposomal bupivacaine after cesarean delivery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Wright State University | Conditions: Pain, Postoperative, Opioid Use | Phase 4 | Status: WITHDRAWN